Evidence map›Paper›PMID 36611697›Full record

ArticleAnimals : an open access journal from MDPI2022

Effect of a Combination of Lysolecithin, Synthetic Emulsifier and Monoglycerides on the Apparent Ileal Digestibility, Metabolizable Energy and Growth Performance of Growing Pigs.

La Van Kinh, Bindhu L Vasanthakumari, C Sugumar, Huyen La Thi Thanh, Nguyen Van Thanh, Alexandra L Wealleans, Le Duc Ngoan, Nguyen Vu Thuy Hong Loan

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

La Van KinhFaculty of Veterinary and Animal Science, HUTECH University, 475A Dien Bien Phu, Ho Chi Minh City 717000, Vietnam.
Bindhu L VasanthakumariKemin Industries, Des Moines, IA 50317, USA.
C SugumarKemin Industries (Asia) Pte Ltd., 12 Senoko Dr, Singapore 758200, Singapore.
Huyen La Thi ThanhInstitute of Animal Sciences for Southern Vietnam, Di An Town, Binh Duong City 82000, Vietnam.
Nguyen Van ThanhInstitute of Animal Sciences for Southern Vietnam, Di An Town, Binh Duong City 82000, Vietnam.
Alexandra L WealleansKemin Animal Nutrition and Health, Kemin Europa N.V., Toekomstlaan 42, 2200 Herentals, Belgium.ORCID 0000-0003-1102-1360
Le Duc NgoanFaculty of Animal Sciences and Veterinary Medicine, Hue University of Agriculture and Forestry, Hue University, 102 Phùng Hưng, Hue City 530000, Vietnam.
Nguyen Vu Thuy Hong LoanFaculty of Veterinary and Animal Science, HUTECH University, 475A Dien Bien Phu, Ho Chi Minh City 717000, Vietnam.
HUTECH UniversityNational Institute of Animal Sciences · VNHue University · VNKemin (Belgium) · BEMilliken & Company (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two studies were conducted to determine the impact of an absorption enhancer containing a combination of lysophospholipids, monoglycerides and synthetic emulsifiers (LEX) on apparent ileal digestibility, metabolizable energy (ME), and growth performance of growing pigs. In the digestibility study, 12 male crossbred [Duroc x (Large White x Landrace)] pigs with an initial body weight (BW) of 30 kg were randomly allocated to two dietary treatments: (1) a positive control (PC) receiving standard diets formulated to 3100 kcal ME/kg, and (2) a negative control formulated with −100 kcal ME/kg and −2.5% AA content vs. PC and supplemented with LEX at 500 g/t. Apparent ileal digestibility of essential AA was significantly increased for lysine, methionine, threonine, histidine, isoleucine and phenylalanine in the LEX treatment (p < 0.05). Average uplift in AA digestibility as a percent of the PC was +1.88%; with greatest improvement for histidine (+4.22%). LEX supplementation effectively compensated energy deficiency of low-density diet and provided additional ME improvement compared to the PC diet (p < 0.05). A second study was conducted to evaluate LEX dose response on the growth performance of pigs fed a low nutrient density diet. Total 450 cross-bred pigs (240 males (castrated) and 210 females) [Duroc x (Large White x Landrace)] with an average initial BW of 7.19 kg were randomly allocated into 4 dietary treatments: (1) a positive control (PC) formulated with standard specifications, (2) a negative control formulated with −100 kcal ME/kg and −2.5% AA content vs. the PC (NC), (3) NC + LEX at 250 g/t (NC + 250) and (4) NC + LEX at 500 g/t (NC + 500). Results showed significant improvement with LEX supplementation on the final BW, average daily gain (ADG) and feed conversion ratio (FCR) of pigs of >50 kg body weight. Across the study, NC + 500 significantly increased ADG vs. PC and NC, and significantly reduced FCR compared to all other treatments. FCR of negative control diets improved by 9 and 15 points with the supplementation of 250 g/t and 500 g/t of LEX, respectively (p < 0.05). FCR in the NC + 250 diet was statistically similar vs. PC, which was significantly reduced compared to the NC. Taken together, these studies demonstrate that the addition of an absorption enhancer containing a combination of lysophospholipids, monoglycerides and synthetic emulsifiers can improve growth performance in growing pigs, driven by increased nutrient digestibility and retention.

Indexed as

apparent ileal digestibilitygrowth performancelysophospholipidsmetabolizable energypigs

Identifiers

PMID36611697
PMCPMC9817515
OpenAlexW4312205841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.